MARKET

ANIP

ANIP

Ani Pharmaceutic
NASDAQ
76.43
+1.66
+2.22%
Opening 15:36 08/14 EDT
OPEN
74.47
PREV CLOSE
74.77
HIGH
76.61
LOW
73.39
VOLUME
123.72K
TURNOVER
--
52 WEEK HIGH
99.50
52 WEEK LOW
70.15
MARKET CAP
1.75B
P/E (TTM)
16.58
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on Top Healthcare Stocks: Sana Biotechnology (SANA), Jade Biosciences (JBIO)
TipRanks · 3d ago
These Analysts Slash Their Forecasts On ANI Pharmaceuticals After Q2 Results
Benzinga · 4d ago
ANI Pharmaceuticals Is Maintained at Buy by Guggenheim
Dow Jones · 4d ago
ANI Pharmaceuticals Price Target Cut to $119.00/Share From $124.00 by Guggenheim
Dow Jones · 4d ago
Guggenheim Maintains Buy on ANI Pharmaceuticals, Lowers Price Target to $119
Benzinga · 4d ago
ANI Pharmaceuticals Is Maintained at Hold by Canaccord Genuity
Dow Jones · 4d ago
ANI Pharmaceuticals Price Target Cut to $90.00/Share From $91.00 by Canaccord Genuity
Dow Jones · 4d ago
Canaccord Genuity Maintains Hold on ANI Pharmaceuticals, Lowers Price Target to $90
Benzinga · 4d ago
More
About ANIP
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in developing, manufacturing, and commercializing therapeutics. Its Rare Disease and Brands segment consists of two reporting units, Rare Disease and Brands. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel and ILUVIEN. The Brands unit includes a portfolio of over 20 branded products that are principally sold in genericized markets. Its Generics and Other segment consists of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.

Webull offers ANI Pharmaceuticals Inc stock information, including NASDAQ: ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.